Sugammadex analog water soluble BCD polymer for peptide complexes
In this work, an integrated biophysical and biological study is presented describing both the structural and biological features of the
Tag: Sugammadex
Sugammadex vs Neostigmine for Reversal of Neuromuscular Blockade and Association with Postoperative Atelectasis After Video-Assisted Thoracoscopic Surgery: A Propensity Score-Matched Cohort Study
Atelectasis means a collapse of the whole lung or an area of the lung. It’s one of the most common breathing
Sugammadex vs. Neostigmine Reversal After Thoracoscopic Thymectomy in Myasthenia Gravis
Rapid and complete reversal of residual neuromuscular blockade (rNMB) is essential for safe postoperative recovery in patients with myasthenia gravis
Results of Phase III clinical trial on efficacy and safety of Adamgammadex
This multicentre, randomised, double-blind, positive-controlled, noninferiority phase III clinical trial aimed to investigate the efficacy and safety of adamagammadex compared
A Comparative Study of Sugammadex and Neostigmine: A Bibliometric Analysis of the Past 15 Years
Sugammadex is a novel selective relaxant binding agent for aminosteroid neuromuscular blocking agents (NMBAs). However, existing literature reveals major knowledge
Repurposing chlorpromazine for anti-leukaemic therapy with the drug-in-cyclodextrin-in-liposome nanocarrier platform
Acute myeloid leukaemia (AML), accounts for 30 % of adult leukaemia cases, predominantly affects individuals over 60. The standard “7 + 3” intensive
Bridion® injection now approved for patients of all ages
Merck Sharp & Dohme LLC has submitted supplemental new drug application which was received on June 12, 2024 by FDA
The Use of Sugammadex as Rescue Therapy Following Inadequate Reversal With Neostigmine – Clinical trial
Neuromuscular blocking agents (NMBAs) are commonly used in the practice of anesthesiology for skeletal muscle relaxation to facilitate tracheal intubation,
Cyclodextrin-containing drugs among top 200 Brand Name Drugs by retail sales
A recent poster by R.E. Williams and C. M. Marshall, (Jon Njardarson’s group, University of Arizona) listed the Top 200
Serving patient’s safety and comfort: Effects of sugammadex vs. neostigmine on postoperative nausea, vomiting and pulmonary complications following general anesthesia.
A recent study published by Korean scientists compared the effect of sugammadex with that of neostigmine in terms of the